$SGMT 4 SEC Filings

Filed On	Filing
17 Aug 2026	Form 4: Kemble George, Director Received 350,987 shares by exercise or conversion ($2.23M) · Sold 350,987 shares ($3.59M)
12 Aug 2026	Form 4: Kemble George, Director Received 20,206 shares by exercise or conversion ($129K) · Sold 20,206 shares ($201K)
22 Jul 2026	Form 4: Happel David, Director Sold 64,051 shares ($497K)
22 Jul 2026	Form 4: Rozek Elizabeth, Chief Legal & Admin. Officer Sold 10,545 shares ($81.8K)
22 Jul 2026	Form 4: Kemble George, Director Sold 18,844 shares ($141K)
15 Jun 2026	Form 4: Seidenberg Beth C, Director Granted 39,567 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Hoelscher Paul W., Director Granted 39,567 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Jarrett Jennifer, Director Granted 39,567 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Grammer Elizabeth A, Director Granted 39,567 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Kemble George, Director Granted 39,567 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Phillips Anne M., Director Granted 39,567 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Chauche Thierry, Chief Financial Officer Granted 50,000 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Grauer Andreas, Chief Medical Officer Granted 35,000 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Rozek Elizabeth, Chief Legal & Admin. Officer Granted 100,000 Stock Option (Right to Buy)
01 Jun 2026	Form 4: Happel David, Director Granted 300,000 Stock Option (Right to Buy)
14 May 2026	Form 4: Grauer Andreas, Chief Medical Officer Granted 264,759 Stock Option (Right to Buy)
20 Feb 2026	Form 4: Rozek Elizabeth, Chief Legal & Admin. Officer Received 44,000 shares as a grant or award · Granted 88,000 Stock Option (Right to Buy)
20 Feb 2026	Form 4: Martins Eduardo Bruno, Chief Medical Officer Received 44,000 shares as a grant or award · Granted 88,000 Stock Option (Right to Buy)
20 Feb 2026	Form 4: Happel David, Director Received 128,000 shares as a grant or award · Granted 256,000 Stock Option (Right to Buy)
20 Feb 2026	Form 4: Chauche Thierry, Chief Financial Officer Received 44,000 shares as a grant or award · Granted 88,000 Stock Option (Right to Buy)

Comments